StockData
MBX Biosciences, Inc. logo

MBX Biosciences, Inc. (MBX) income statement

MBXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$49.55−3.86 (-7.23%)

Close on Nov 20, 2026Market cap $2.39BP/E –Yield –

See a number that looks wrong?